The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Mechanism of Inhibition of P-Glycoprotein Mediated Efflux by Vitamin E TPGS: Influence on ATPase Activity and Membrane Fluidity
Abstract
Efflux pump (e.g., P-gp, MRP1, and BCRP) inhibition has been recognized as a strategy to overcome multi-drug resistance and improve drug bioavailability. Besides small-molecule inhibitors, surfactants such as Tween 80, Cremophor EL, several Pluronics, and Vitamin E TPGS (TPGS 1000) are known to modulate efflux pump activity. Competitive inhibition of substrate binding, alteration of membrane fluidity, and inhibition of efflux pump ATPase have been proposed as possible mechanisms. Focusing on TPGS 1000, the aim of our study was to unravel the inhibitory mechanism by comparing the results of inhibition experiments in a Caco-2 transport assay with data from electron spin resonance (ESR) and from ATPase activity studies. ESR results, on Caco-2 cells using 5-doxyl stearic acid (5-SA) as a spin probe, ruled out cell membrane fluidization as a major contributor; change of membrane fluidity was only observed at surfactant concentrations 100 times higher than those needed to achieve full efflux inhibition. Concurrently, TPGS 1000 inhibited substrate induced ATPase activity without inducing significant ATPase activity on its own. By investigating TPGS analogues that varied by their PEG chain length, and/or possessed a modified hydrophobic core, transport studies revealed that modulation of ATPase activity correlated with inhibitory potential for P-gp mediated efflux. Hence, these results indicate that ATPase inhibition is an essential factor in the inhibitory mechanism of TPGS 1000 on cellular efflux pumps.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ABC Transporters: From Microorganisms to Man
Higgins, C. F. (1992) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.08.110192.000435 · Cited by 3,985
The Enzymes of Biological Membranes
(1985) · Springer eBooks · doi:10.1007/978-1-4613-2355-6 · Cited by 1,354
Multidrug resistance (MDR) in cancer
Krishna, R., & Mayer, L. D. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00114-7 · Cited by 1,026
Importance of P-glycoprotein at blood–tissue barriers
Fromm, M. F. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.06.002 · Cited by 592
Lipid regulation of cell membrane structure and function
Yèagle, P. L. (1989) · The FASEB Journal · doi:10.1096/fasebj.3.7.2469614 · Cited by 513
Impact of Drug Transporter Studies on Drug Discovery and Development
Mizuno, N., Niwa, T., Yotsumoto, Y., & Sugiyama, Y. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.3.1 · Cited by 490
Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo
Cornaire, G., Woodley, J., Hermann, P., Cloarec, A., Arellano, C., & Houin, G. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.03.001 · Cited by 307
Batrakova, E. V., Li, S., Vinogradov, S. V., Alakhov, V. Y., Miller, D. W., & Kabanov, A. V. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29254-5 · Cited by 292
Suzuki, H., & Sugiyama, Y. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00178-0 · Cited by 291
Reversal of multidrug resistance by surfactants
Woodcock, D., Linsenmeyer, M., Chojnowski, G., Kriegler, A., Nink, V, Webster, L., & Sawyer, W. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.217 · Cited by 233
Batrakova, E. V., Li, S., Elmquist, W. F., Miller, D. W., Alakhov, V. Y., & Kabanov, A. V. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2165 · Cited by 229
Hunter, J., Hirst, B. H., & Simmons, N. L. (1993) · Pharmaceutical Research · doi:10.1023/a:1018972102702 · Cited by 223
Bogman, K., Erne-Brand, F., Alsenz, J., & Drewe, J. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10395 · Cited by 184
Collnot, E.-M., Baldes, C., Wempe, M. F., Hyatt, J., Navarro, L., Edgar, K. J., Schaefer, U. F., & Lehr, C.-M. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.11.005 · Cited by 184
Self-citationDrori, S., Eytan, G. D., & Assaraf, Y. G. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.1020m.x · Cited by 179
Effect of Pluronic P85 on ATPase Activity of Drug Efflux Transporters
Batrakova, E. V., Li, S., Li, Y., Alakhov, V. Y., & Kabanov, A. V. (2004) · Pharmaceutical Research · doi:10.1007/s11095-004-7675-5 · Cited by 158
Reversal of Multidrug-Resistance Phenotype by Surfactants: Relationship to Membrane Lipid Fluidity
Dudeja, P. K., Anderson, K. M., Harris, J. S., Buckingham, L. E., & Coon, J. S. (1995) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1995.1298 · Cited by 143
Miller, D. W., Batrakova, E. V., & Kabanov, A. V. (1999) · Pharmaceutical Research · doi:10.1023/a:1018873702411 · Cited by 124
An EPR investigation of surfactant action on bacterial membranes
Glover, R. E., Smith, R., Jones, M. V., Jackson, S. K., & Rowlands, C. C. (1999) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1999.tb13713.x · Cited by 110
Allosteric Modulation of Human P-glycoprotein
Maki, N., Hafkemeyer, P., & Dey, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210413200 · Cited by 94
Martin, C., Berridge, G., Higgins, C. F., & Callaghan, R. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701429 · Cited by 82
Nörenberg, W., Wirkner, K., & Illés, P. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701347 · Cited by 76
A High-Throughput Screening Microplate Test for the Interaction of Drugs with P-Glycoprotein
Garrigues, A., Nugier, J., Orlowski, S., & Ezan, É. (2002) · Analytical Biochemistry · doi:10.1006/abio.2002.5650 · Cited by 75
Schuldes, H., Dolderer, J. H., Zimmer, G., Knobloch, J., Bickeböller, R., Jonas, D., & Woodcock, B. G. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00450-0 · Cited by 50
Sweet, W. D., & Schroeder, F. (1986) · Biochemical Journal · doi:10.1042/bj2390301 · Cited by 39
Dolderer, J. H., Zimmer, G., Woodcock, B. G., Bockhorn, H., Bickeböller, R., & Schuldes, H. (2000) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp38196 · Cited by 15
Cited by
Xu, W., Ling, P., & Zhang, T. (2013) · Journal of Drug Delivery · doi:10.1155/2013/340315 · Cited by 595
Oral lipid-based drug delivery systems – an overview
Kalepu, S., Manthina, M., & Padavala, V. (2013) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2013.10.001 · Cited by 494
Very important pharmacogene summary
Hodges, L. M., Markova, S. M., Chinn, L. W., Gow, J. M., Kroetz, D. L., Klein, T. E., & Altman, R. B. (2011) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3283385a1c · Cited by 436
Recent Advances in the Application of Vitamin E TPGS for Drug Delivery
Yang, C., Wu, T., Qi, Y., & Zhang, Z. (2018) · Theranostics · doi:10.7150/thno.22711 · Cited by 402
Recent progress in biomedical applications of pluronic (PF127): Pharmaceutical perspectives
Akash, M. S. H., & Rehman, K. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.04.032 · Cited by 394
Metadata
- Authors
- Collnot, E.-M., Baldes, C., Wempe, M. F., Kappl, R., Hüttermann, J., Hyatt, J. A., Edgar, K. J., Schaefer, U. F., & Lehr, C.-M.
- Venue
- Molecular Pharmaceutics
- Publisher
- American Chemical Society (ACS)
- Published
- 2007-03-17
- Volume
- 4
- Issue
- 3
- Pages
- 465-474
- ISSN
- 1543-8384 (ISSN-L)
- 1543-8392
- OpenAlex
- W2045128339
- Cited by
- 280
- References
- 26
- FWCI
- 4.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.